SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

July 30, 2004

(Date of earliest event reported)

 

ABIOMED, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

0-20584

 

04-2743260

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

 

 

22 Cherry Hill Drive, Danvers, Massachusetts

 

 

 

01923

(Address of principal executive offices)

 

 

 

(Zip Code)

 

 

 

 

 

(978) 777-5410

(Registrant’s telephone number, including area code)

 

 

 

 

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

 



 

Item 7.                                                           Financial Statements and Exhibits.

 

 

(c) Exhibits

 

 

 

 

 

 

Exhibit Number

 

Description

 

99.1

 

Press release dated July 30, 2004

 

 

Item 12.                                                    Results of Operations and Financial Condition.

 

On July 30, 2004, ABIOMED, Inc. announced its financial results for its first fiscal quarter ending June 30, 2004.  The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

ABIOMED, Inc.

 

 

 

 

 

 

 

By:

/s/ Charles B. Haaser

 

 

 

Charles B. Haaser

 

 

 

Controller

 

 

 

Principal Accounting Officer

 

 

 

Principal Financial Officer

 

 

 

Date:  July 30, 2004

 

3



 

Exhibit Index

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press release dated July 30, 2004

 

4